Background Periodic surveillance of the hepatitis C virus (HCV) care cascade is important
for tracking progress toward HCV elimination goals, identifying gaps in care, and prioritizing …

Abstract Background: Reaching World Health Organization hepatitis C (HCV) elimination
targets requires diagnosis and treatment of people who use drugs (PWUD) with direct acting …

Background Chronic hepatitis C virus (HCV) infection contributes to substantial morbidity
and mortality among adults living with HIV. Cascades of HCV care support monitoring of …

People living with HIV-HCV co-infection comprise a target group for HCV-micro-elimination.
We conducted an HCV cascade of care (CoC) for HIV-HCV co-infected individuals living in …

Introduction Hepatitis C virus (HCV) prevalence among transgender and gender-diverse
individuals ranges from 1.8% to 15.7% versus 1% in the general population. Previous HCV …

Background and Objectives: Direct-acting antiviral agents (DAA) are a safe and highly
effective treatment for hepatitis C virus (HCV) infection. However, the uptake of DAA …

Objectives: Highly effective direct-acting antiviral medications have made it feasible to
achieve elimination of hepatis C virus (HCV), including for people with HIV and HCV …

Background Hepatitis C remains highly prevalent among people who inject drugs (PWIDs).
We propose an integrated approach for screening/diagnostic testing and treatment in 6,665 …

Background Direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) is well tolerated,
cost-effective, and yields high sustained virologic response rates, yet it has remained …

Abstract Introduction: Hepatitis C virus (HCV) infection remains a major public health
problem worldwide. In Burkina Faso, nearly 720,000 people are living with HCV, and each …